Clinical Trial

Physiological and QoL Benefits of Qi-Gong in Post-acute Sequelae of Covid-19

Study acronym: QG-PASC
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 17, 2025 (before its estimated April 7, 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to determine whether Qi-Gong can improve physiological function and quality of life (QoL) in individuals with post-acute sequelae of SARS-CoV-2 infection (PASC). Study Objectives: To assess whether Qi-Gong improves physiological function in individuals with PASC. To evaluate whether Qi-Gong enhances quality of life in individuals with PASC. Study Design: If a comparison group is included, researchers will compare Qi-Gong with standard care to assess its effectiveness. Participant Involvement: Practice Qi-Gong three times per week for three months. Record physiological data monthly.
Trial Details
NCT Number NCT06879925
Lead Sponsor POCHIWU
Conditions PASC Post Acute Sequelae of COVID 19
Enrollment 80 participants
Start Date 2024-12-02
Primary Completion 2025-04-07 (estimated)
Study Completion 2025-04-07 (estimated)
Updated on ClinicalTrials.gov 2025-03-17